Netcompany - Transactions in connection with share buyback programme

Udgivet den 13-05-2021  |  kl. 09:38  |  

Company announcement
No. 10/2021

                                                                                                             13 May 2021

Transactions in connection with share buyback programme
On 6 May 2021, Netcompany Group A/S ("Netcompany") announced that a share buyback programme of up to DKK 50m and a maximum of 125,000 shares had been initiated with the purpose of meeting Netcompany's future commitments under its LTIP programmes (RSU). The share buyback programme is executed in accordance with EU Market Abuse Regulation, EU Regulation no. 596/2014 of 16 April 2014 and the provisions of Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Regulation"). The share buyback programme will end no later than 2 June 2021.

Transactions made under the share buyback programme will be announced through Nasdaq Copenhagen on a weekly basis.

The following transactions have been executed in the period 6 May 2021 to 12 May 2021:

  Number of shares Average purchase price, DKK Transaction value, DKK
06-05-2021 8,000 646.99 5,175,920
07-05-2021 7,000 648.54 4,539,780
10-05-2021 5,000 671.85 3,359,250
11-05-2021 8,000 648.20 5,185,600
12-05-2021 8,000 639.52 5,116,160
Accumulated for the period 36,000 - 23,376,710
Accumulated under the programme 36,000 - 23,376,710

Detailed information on all transactions under the share buyback programme during the period is included in the attached appendix.

Following the above transactions, Netcompany owns a total of 935,813 treasury shares corresponding to 1.87% of the total share capital.

Additional information

For additional information, please contact

Netcompany Group A/S

Thomas Johansen, CFO
+45 51 19 32 24

Tine K. Boye, General Counsel
+45 24 91 75 33

Attachments

10. Transactions in connection with share buyback programme 10a. Information on all transactions

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

17:49 Europa/lukning: Danske fedmeaktier blødte og trak Europa i rødt
17:19 Fredagens obligationer: Renter faldt efter amerikanske inflationstal
17:18 Novo banket i bund efter skuffende data - aktionærerne tabte omkring 690 mia. kr.
17:06 Fredagens aktier: Øretæver til Novo Nordisk og Zealand Pharma giver solid C25-nedtur
15:46 USA/åbning: Eli Lilly vinder på Novos kollaps mens inflationsdata skærer lidt af dykket
15:17 Jeudan har milliarder klar til opkøb: "Øget optimisme kan give flere transaktioner i 2025"
15:15 Novo/Jyske Bank: Kursreaktion virker som overreaktion
14:29 USA/tendens: Eli Lilly vinder på Novos kollaps mens frygt for nedlukning varsler rød start
13:33 Korr: Udsalg af Novo-aktier presser kronen
13:24 Udsalg af Novo-aktier presser kronen
12:29 Sydbank-analytiker: Voldsomt kursfald afspejler skuffelsen over Cagrisema-data
12:25 Europa/aktier: Danske fedmeaktier bløder og trækker Europa i rødt
12:22 Novo smadres på børsen efter skuffende fedmestudie - aktien taber 770 mia. kr.
12:11 Novos styrtdyk trækker C25-indekset ned i sit fjerdestørste fald nogensinde
12:09 Gubra og Zealand Pharma trækkes med ned af negativt nyt til Novo Nordisk
12:05 Novo lever ikke op til egne forventninger i vigtigt studie - aktien mister 900 mia kr -NY2
11:56 Novo lever ikke op til egne forventninger i kursfølsomt studie - aktien mister 700 mia kr
11:48 Aktier/middag: Zealand Pharma bankes tocifret ned efter FDA-afvisning og trækker C25 ned
11:28 Obligationer/middag: Små renteudsving før inflationsnyt fra USA
10:49 Jefferies ser kurslussing til Zealand Pharma som købsmulighed